Wnt3a is implicated in several key cellular processes and its expression has been reported in different cell types. Here, we report a novel function for Wnt3a in macrophages, whose exposure to this ligand shifts them towards a pro-angiogenic phenotype capable, under oxygen and glucose deprivation, of inducing in vitro tubular pattern structures in endothelial cells resembling capillary-like vasculature. These newly acquired angiogenetic features also include increased proliferation and migration and surprisingly, an increase in cell death. This work provides a new link between Wnt3a and macrophage-mediated angiogenesis under glucose and oxygen deprivation in vitro, which are worth further investigation in pathological conditions including stroke, where the stimulation of the angiogenic process might help to recovery after tissue injury
Introduction
Wnt ligands constitute a family of secreted glycoproteins which are cell-and tissue-specific ligands that orchestrate a wide range of processes in the developing and adult brain. 1 In mammals, a total of 19 proteins have been identified and divided into two classes: the Wnt1 subtype (including Wnt3a), generally triggering the canonical Wnt/b-catenin signaling pathway and the Wnt5a type, which operates via the non-canonical Wnt/planar cell polarity or Wnt/Ca 2 þ pathways.
Impact statement
This work provides a new link between Wnt3a and macrophage-mediated angiogenesis under glucose and oxygen deprivation in vitro. Our results reveal how Wnt3a shifts macrophages towards a proangiogenic phenotype, which is able-in absence of both glucose and oxygen-of inducing angiogenesis in vitro, thus pointing to a synergy between the activation of the pathway and the hypoxia scenario. This work also demonstrates that modulation of cell death is key in order to explain the observed angiogenic effects.
We consider all these findings of significant importance, since no connection between Wnt3a, macrophages, and angiogenesis has been established so far. Furthermore, we do believe that this work provides new and interesting results, with Wnt signaling pathway emerging as an interesting target mediating beneficial outcomes during the inflammatory response undoubtedly linked to stroke pathology, where angiogenesis has been already proposed as a potential mechanism to promote recovery after the injury.
Several evidences point out a role for Wnt signaling in angiogenesis, the formation of new blood vessels from the existing vasculature. Indeed, endothelial cells (ECs) express several Wnt receptors and modulators. 2 On the other hand, it is known that Wnt signaling participates in the induced neuroinflammatory response associated to several neurological disorders including stroke 3 and that specifically Wnt3a induces anti-inflammatory effects in macrophages (Mu), which in turn acquire regenerative properties. 1 Mu constitute a self-renewing tissue-resident population that performs an important immune surveillance function as well as contribute to tissue homeostasis by removing dead cells and toxic materials. 4 A relevant role for Mu in both pathological and physiological angiogenesis has also been described. Mu seem to be essential during normal development but they also regulate angiogenesis during tissue injury and repair in the adulthood by secreting trophic factors and contributing to carve out tunnels in the extracellular matrix providing avenues for subsequent capillary infiltration. 5 Finally, Mu are actively involved in several neurological conditions such as stroke, where they play complex and multifaceted roles. 6 Interestingly, in stroke, overexpression of angiogenic factors is induced after the injury and new capillaries are formed within days after the onset of the ischemia. 7 Thus, understanding the mechanisms regulating angiogenesis might represent an interesting target to look at in post-stroke molecular therapies.
Despite the link Wnt signaling-Mu-angiogenesis has been suggested in some reports, 5 no connection relative to Wnt3a has been established so far.
Our data demonstrate that Wnt3a and hypoxia act synergistically to promote angiogenesis by regulating essential mechanisms where cell death regulation seems to play a pivotal role.
Material and methods

Reagents
The following reagents were used: Recombinant Wnt3a (R&D Systems, Minneapolis, USA), RNeasy Mini Kit (Qiagen, Hilden, Germany), Proteome Profiler Mouse Angiogenesis Array Kit (ARY015, R&D Systems), Matrigel Matrix Growth Factor Reduced (Corning, NY, USA), LDH cytotoxicity Assay kit (Abcam, Cambridge, UK).
Cell culture and Wnt3a treatment SVEC4-10 Mus Musculus axillary lymph node cells (kindly gift from Prof. Geoffrey L Smith, University of Cambridge, UK) were routinely grown in Dulbecco's modified Eagle's medium (DMEM), containing 10% fetal bovine serum (FBS), 2 mM of L-glutamine, 100 U/mL penicillin, and100 mg/mL streptomycin at 37 C in a 5% CO 2 atmosphere. Mu were prepared by flushing bone marrow from femurs and tibia of wild-type (WT) C57BL/6 female mice. Cells were cultured in differentiating DMEM medium containing 20% of M-CSF at 37 C in a 5% CO 2 atmosphere for six days. Differentiated Mu were then treated with 300 ng/ml recombinant Wnt3a using 1% BSA-PBS as vehicle (control) for 6 h. After this time, media were collected for angiogenesis array experiments or replaced by fresh 
Results
Wnt3a shifts Mu towards a pro-angiogenic phenotype
Given the ability of Wnt3a to induce the expression of several cytokines, 8 we wonder whether this ligand would be able to provoke any change in the secretion levels of different angiogenic factors in Mu. Thus, we stimulated these cells with 300 ng/ml of recombinant Wnt3a, a dose able to activate the pathway as we observed in previous experiments (see Figure S1(a) ). An angiogenesis proteome profile was then carried out (Figure 1(a) and Figure S1 (b)). Wnt3a significantly increased secretion of several factors considered as pro-angiogenic according to the literature. 9 On the other hand, other molecules known to have anti-angiogenic effects were found significantly decreased upon treatment (Figure 1(b) and (c)), suggesting a shift towards an angiogenic phenotype. Additionally, in a reduced number of cases (including fractalkine, interferon gamma-induced protein 10, IP-10 and hepatocyte growth factor, HGF), Wnt3a had an effect opposite of expected (see Figure S1(b) ).
Wnt3a treatment and OGD act synergistically to promote angiogenesis in vitro
A stroke is a serious life-threatening medical condition characterized by the interruption of blood flow and oxygen and glucose supply, which induce severe tissue damage and where angiogenesis has been proposed as a harmonized target for recovery after the injury. 10 To investigate whether the Wnt3a-induced pro-angiogenic phenotype observed in Mu might have any effect on angiogenesis under homeostatic conditions and after OGD, which has been widely used as an in vitro model for stroke, 11 we performed conditioned medium (CM) experiments in SVEC4-10 ECs in both conditions. To avoid Wnt3a-mediated direct effects, CM was prepared by adding fresh medium to macrophages after Wnt3a treatment 24 h before transferring it to ECs (see Material and methods). As shown in Figure 2 (see also Figure S2 ), although not statistically significant, medium derived from untreated Mu was able per se to induce an increase in tubular formation in both control and OGD conditions. When we looked at the effects induced by Mu Wnt3a CM, an increase in different angiogenic parameters was much more evident in OGD samples, pointing to a synergy between both Wnt3a treatment and oxygen and glucose withdrawal.
Mu
Wnt3a CM increases ECs migration regardless the oxygen/glucose levels Migration of ECs, an essential process involved in angiogenesis 12 was then quantified. After 6 h of treatment with 
Wnt3a CM differentially affects cell death and proliferation under OGD conditions Proliferation and cell death are also essential processes underlying angiogenesis. 12 Upon treatment with Mu Wnt3a CM, increased proliferation rate in ECs in both normal and OGD conditions was observed with minimum effects in Mu CM samples (Figure 4 (a) and (b); Figure S3(a)) . Surprisingly, when cell viability was quantified, a general increase in cell death was observed upon treatment with CM, which was remarkably higher in ECs that had been treated with Mu Wnt3a CM and subjected to OGD (Figure 4 (c); Figure S3(b) ). Although as a whole, gross proliferation percentages (not relativized to Normal medium condition) were higher than the ones corresponding to cell death in all analyzed settings (data not shown), when cell proliferation/cell death ratio was calculated, a clear decrease when Wnt3a treatment and OGD conditions converged was observed, highlighting that cell viability was indeed key to understand the angiogenic effects observed under those conditions ( Figure S3(c) ).
Discussion
Angiogenesis is regulated by a tight balance between proand anti-angiogenic agents and involves a cascade of events of which proliferation, apoptosis, and migration of capillary ECs are essential components. 12 Here, we report how Wnt3a, a member of the canonical Wnt signaling pathway, is able to modulate this balance in Mu, making them acquire a pro-angiogenic phenotype capable of inducing the formation of new EC tubular structures (capillary-like structures) in vitro. We have detected that secretion of eighteen different factors is regulated by exposure to recombinant Wnt3a, being over 65% of them (12/18) Wnt3a is able to slightly stimulate tubular formation in control conditions, confirming the previously reported participation of Mu in the process. 5 However, in OGD, only CM derived from Mu Wnt3a induced a clear and statistically significant positive effect on in vitro angiogenesis, pointing to a synergistic effect between the activation of this pathway and the deprivation of these two essential components in ECs. This synergy might be explained if we take into consideration that, on one hand, some of the factors that Fuster-Matanzo et al. Pro-angiogenic features in macrophages 25   ............................................................................................................................................................... are up regulated by Wnt3a treatment (such as Amphiregulin, KC, angiogenin and macrophage inflammatory protein 1-alpha, MIP-1a) are known targets of the hypoxia inducible factor-1 (HIF-1) pathway, the master regulator of oxygen homeostasis. [13] [14] [15] [16] On the other hand, other measured factors in our study are known to regulate the expression of HIF-1 transcription factors, such as CXCL16 and basic fibroblast growth factor, FGF (both increased in our model), which up regulates HIF-1a 17, 18 or endostatin and prolactin (both decreased in our model), which have been demonstrated to down regulate HIF-1a levels and activity. 19, 20 As a result, this would generate a positive loop that would account for the net increase in in vitro angiogenesis upon Wnt3a CM treatment and oxygen and glucose withdrawal that we observe. Interestingly, Mu Wnt3a CM is able to promote EC migration and proliferation in both control and OGD with a similar tendency, but has a differential positive effect on the net cell death rate. Firstly, it is known that hypoxia and glucose deficiency per se induce apoptosis. 21 Secondly, some factors released by Mu upon Wnt3a treatment might have a critical role in the regulation of this process. Thus, some of the mentioned pro-angiogenic factors such as IL-10, amphiregulin, CXCL16, and basic FGF, despite having several anti-apoptotic effects, have been also reported to produce opposite outcomes. [22] [23] [24] [25] Interestingly, some factors like fractalkine, IP-10, or HGF, whose regulation in our experimental conditions would not point towards a pro-angiogenic phenotype, might have relevant roles in ECs apoptosis regulation though. The decrease in fractalkine and HGF, with known anti-apoptotic effects 26, 27 along with the increase in IP-10, involved in apoptosis induction 28 could create a favorable environment for ECs cell death. Although it seems counterintuitive that EC apoptosis may contribute to vascular morphogenesis, this process might have an important role in deleting wrongly placed EC as nascent vessels enlarge. Indeed, several vascular phenotypes have been described in mice in which regulators of EC apoptosis are disrupted, 29 supporting the idea of this process as a necessary event for proper angiogenesis.
Ischemic stroke is currently the third most frequent cause of mortality in industrialized countries. 30 Consequently, it is presently of outmost importance to shed additional light and provide fundamental information on understanding the basic mechanisms underlying the pathology, which could represent possible steps towards prevention and therapeutic intervention. In this sense, angiogenesis might be a relevant target process whose up regulation would have several beneficial effects in the hours to weeks after the ischemic injury, such as the promotion of cell survival by growth factors release, the enhancement of neurogenesis by creation of a "vascular niche" or the facilitation of tissue regeneration by allowing Mu to have access to necrotic brain tissue contributing to its removal. 10 Indeed, a powerful relation between Mu and microvessel density after cerebral ischemia has been described, 31 thus highlighting the role of mononuclear phagocytes in the post-ischemia angiogenic process.
Although more studies are required to understand the mechanisms triggered by Wnt3a under OGD conditions, our data support the idea of this pathway as an interesting target mediating beneficial outcomes during the inflammatory response in hypoxia; a process that might be worthy to further explore for the development of possible stroke therapies.
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